Abstract
Lymphokines are proteins or glycoproteins synthesized by lymphoid cells upon stimulation by a variety of triggering events and which exert a messenger and/or mediator function in the immune system. This usual definition, however, is too narrow, since some characterized lymphokines have been shown to be produced also by non lymphoid cells and even to produce their effects outside of the immune system (Mizel et al., 1980; Schmidt et al., 1982; Fontana et al., 1982; Besedovsky et al., 1983; Postlewhaite et al., 1983), hence the more general term of cytokines. Indeed, it is increasingly evident that the biologically active glycoproteins and proteins produced by activated lymphoid cells have manifold functions, also on several other systems, like the brain and the neuroendocrine system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
ADELMAN, N.E., HAMMOND, M.E., COHEN, S. and DVORAK, H. (1979). Lymphokines as inflammatory mediators. In Biology of the Lymphokines Cohen, S., Pick, E., Oppenheim, J.J. (eds) pp. 13–58, New York: Academic Press.
ALTMAN, A., THEOPHILOPOULOS, A.N., WEINER, R., KATZ, D.H. and DIXON, F.J. (1981). Analysis of T cell function in autoimmune murine strains. Defects in production of and responsiveness to interleukin 2. J. Exp. Med., 154, 791–808.
ANDERSSON, J. and MELCHERS, F. (1981). T cell-dependent activation of resting B cells: requirement for both nonspecific unrestricted and antigen-specific Ia-restricted soluble factors. Proc. Nam. Acad. Sci. U.S.A., 78, 2497–2501.
BESEDOVSKY, H.O., del REY, A.E. and SORKIN, E. (1983). What do the immune system and the brain know about each other? Immunology Today, 4, 346–349.
BONNARD, G.D., YASAKA, K. and JAKOBSON, D. (1979). Ligand-activated T cell growth factor-induced proliferation: Absorption of T cell growth factor by activated T cells. J. Immunol., 123, 2704–2708.
BOOTH, R.J., PRESTIDGE, R.L. and WATSON, J.D. (1983). Constitutive production by the WEHI-3 cell line of a B cell growth and differentiation factor that co-purifies with interleukin 1. J. Immunol., 131, 1289–1293.
BOOTH, R.J., PANG, G.T.M., WATSON, J.D. (1984). Interleukin-2 is required for the induction of erythrocyte-specific antibody responses in human lymphocyte cultures. J. Biol. Resp. Modif., 3, 206–218.
BOROS, D.L. (1980). The role of lymphokines in granulomatous inflammations. In Lymphokines. Pick, E. and Landy, M. (eds) pp. 257–281, New York: Academic Press.
BROMBERG, Y. and PICK, E. (1983). Unsaturated fatty acids as second messengers of superoxide generation by macrophages. Cell. Immunology, 76, 240–252.
BUTLER, J.L., MURAGUCHI, A., LANE, H.C. and FAUCI, A.S. (1983). Development of a human T-T cell hybridoma secreting B cell growth factor. J. Exp. Med., 157, 60–68.
BUTLER, J.L., AMBRUS, J.L. Jr and FAUCI, A.S. (1984). Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma. J. Immunol., 133, 251–255.
CURTSINGER, J.M. and FAN, D.P. (1984). Interleukin 3 augments the murine primary cytolytic T lymphocyte response to allogenic tumor cells. J. Immunol., 133, 267–272.
DAUPHINEE, M.J., KIPPER, S.B., WOFSY, D. and TALAL, N. (1981). Interleukin 2 deficiency is a common feature of autoimmune mice. J. Immunol., 127, 2483–2485.
De WECK, A.L. (1981). Lymphokines and other immunoactive soluble cellular products: Prospects for the future. In Lymphokines and thymic hormones. Their potential utilization in cancer therapeutics. Progress in Cancer Research and Therapy, vol20. Goldstein, A.L. and Chirigos, M.A. (eds) pp. 1–13, New York: Raven Press.
DINARELLO, C.A. (1982). Human pyrogen: a monocyte product mediating host defences. In Advances in Host Defence Mechanisms vol. 1. Gallin, J.I. and Fauci, A.S. (eds) pp. 57–74, New York: Raven Press.
EBERLEIN, T., ROSENSTEIN, M. and ROSENBERG, S.A. (1982). Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2. J. exp. Med., 156, 385–397.
FALKOFF, R.J.M., ZHU, L.P. and FAUCI, A.S. (1982). Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus. Evidence for a two-signal model of B cell activation. J. Immunol., 129, 97–102.
FARRAR, J.J., BENJAMIN, W.R., HILFIKER, M.L., HOWARD, M., FARRAR, W.L. and FULLER-FARRAR, J. (1982). The biochemistry, biology and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses. Immunol. Rev., 63, 129–166.
FLOMENBERG, N., WELTE, K., MERTELSMAN, R., KERNAN, N., CIOBANU, N., VENUTA, S., FELDMAN, S., KRUGER, G., KIRKPATRICK, D., DUPONT, B. and O’REILLY, R. (1983). Immunologic effects of interleukin 2 in primary immunodeficiency diseases. J. Immunol., 130, 2644–2650.
FONTANA, A. and GROB, P.J. (1984). Lymphokines and the brain. In Seminars in Immunopathology. Miescher, P. and Muller-Eberhardt, H.J. (eds) Heidelberg: Springer Verlag (in press).
FONTANA, A., OTZ, U., de WECK, A.L. and GROB, P.J. (1982). Glia cell stimulating factor (GSF): a new lymphokine. 2. Cellular sources and partial purification of human GSF. J. Neuroimmunol., 2, 73.
GATELY, C.L. and OPPENHEIM, J.J. (1982). Activation of macrophages by lymphokines: a factor which induces hydrogen peroxide production by macrophage-like cell lines. Fedn Proc., 41, 768 (abstr.).
GEMSA, D. (1981). Stimulation of prostaglandin E release from macrophages and possible role in the immune response. In Lymphokines. vol. 4. Pick, E. and Landy, M. (eds) pp. 335–394, New York: Academic Press.
GILLIS, S. (1983). Interleukin 2: Biology and Biochemistry. J. clin. Immunol., 3, 1–13.
GILLIS, S., GILLIS, A.E. and HENNEY, C.S. (1981a). Monoclonal antibody directed against interleukin 2. I. Inhibition of T lymphocyte mitogenesis and the in vitro differentiation of alloreactive cytolytic T cells. J. exp. Med., 154, 983–988.
GILLIS, S., KOZAK, R., DURANTE, M. and WEKSLER, M.E. (1981b). Immunologic studies of aging. Decreased production of and response to T-cell growth factor by lymphocytes from aged humans. J. clin. Invest., 67, 937.
GOODWIN, J.S. and WEBB, D.R. (1980). Regulation of the immune response by prostaglandins. Clin. Immun. Immunopath., 15, 106–122.
HOWARD, M. and PAUL, W.E. (1983). Regulation of B cell growth and differentiation by soluble factors. A. Rev. Immun., 1, 307–333.
HOWARD, M., FARRAR, J., HILFIKER, M., JOHNSON, B., TAKATSU, K. and PAUL, W.E. (1982a). Identification of a T-cell derived B-cell growth factor distinct from interleukin 2. J. exp. Med., 155, 914–923.
HOWARD, M., NAKANISHI, K. and PAUL, W.E. (1982b). Accessory cell derived factors required for anti-Ig induced B cell proliferation. J. Cell Biochem. (Supp1.6), 63.
HOWARD, M., MIZEL, S.B., LACHMAN, L., ANSEL, J., JOHNSON, B. and PAUL, W.E. (1983). Role of interleukin 1 in anti-immunoglobin-induced B cell proliferation. J. exp. Med., 157, 1529–1543.
IHLE, J.N., REBAR, L., KELLER, J., LEE, J.C. and HAPEL, A. (1981). Interleukin 3: possible roles in the regulation of lymphocytes differentiation and growth. Immunol. Rev., 63, 5–32.
JOHNSON, H.M. and FARRAR, W.L. (1983). The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptors. Cell Immunol., 75, 154–159.
JOHNSTON, R.B. (1981). Enhancement of phagocytosisassociated metabolism as a manifestation of macrophage activation. In Lymphokines. vol. 3. Pick, E. and Landy, M. (eds) pp. 33–56, New York: Academic Press.
JONCOURT, F., WANG, Y., KRISTENSEN, F. and de WECK, A.L. (1982). Aging and immunity: Decrease in Interleukin 2 production and interleukin 2-dependent RNA synthesis in lectin-stimulated murine spleen cells. Immunobiology, 163, 521–526.
KASAKURA, S., TAGUCHI, M., WATANABE, Y., OKUBO, T., MURACHI, T., UCHINO, H. and HANAOKA, M. (1983). Suppressor cell induction factor: a new mediator released by stimulated human lymphocytes and distinct from previously described lymphokines. J. Immunol., 130, 2720–2726.
KIMBALL, E.S., PICKERAL, S.F., OPPENHEIM, J.J. and ROSSIO, J.L. (1984). Interleukin 1 activity in normal human urine. J. Immunol., 133, 256–260.
KRAMER, M. and KOSZINOWSKI, U. (1982). T-cell specific suppressor factor (s) with regulatory influence on interleukin 2 production and function. J. Immunol., 128, 784–790.
KRISTENSEN, F. and de WECK, A.L. (1982). Use of cytofluorometric techniques for assay of cell cycle regulating lymphokines. In Human Lymphokines: the biological immune response modifiers. Khan, A. and Hill, N.O. (eds) pp. 451–457, New York: Academic Press.
KRISTENSEN, F., WALKER, C., BETTENS, F., JONCOURT, F. and de WECK, A.L. (1982). Assessment of IL 1 and IL 2 effects on cycling and non cycling murine thymocytes. Cell. Immunol., 74, 140–149.
KRISTENSEN, F., BETTENS, F., WALKER, C., JONCOURT, F. and de WECK, A.L. (1983). Relationship between cell cycle events and interleukin 2 (IL 2) production. In Role of lymphokines and cytokines in immunoregulation. Oppenheim, J.J. and Cohen, S. (eds) pp.451–458, New York: Academic Press.
LEE, J.C., HAPEL, A.J. and IHLE, J.N. (1982). Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line. J. Immunol. 128, 2393–2398.
LEIBSON, H., MARRACK, P. and KAPPLER, J. (1981). B cell helper factors. I. Requirement for both interleukin 2 and another 40,000mol wt factor. J. exp. Med., 154, 1681–1693.
LEONARD, W.J., DEPPER, J.M., UCHIYAMA, T., SMITH, K.A., WALDMAN, T.A. and GREEN, W.C. (1982). A monoclonal antibody that appears to recognize the receptor for human T cell growth factor; partial characterization of the receptor. Nature, 300, 267–269.
LINKER-ISRAELI, M., BAKKE, A.C., KITRIDOU, R.C., GENDLER, S., GILLIS, S. and HORWITZ, D.A. (1983). Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J. Immunol., 130, 2651–2655.
LIPSKY, P.E., THOMPSON, P.A., ROSENWASSER, L.J. and DINARELLO, C.A. (1983). The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen. J. Immunol., 130, 2708–2714.
LOPEZ-BOTET, M., FONTAN, G., RODRIGUEZ, M.C.G. and DE LANDAZURI, M.O. (1982). Relationship between IL2 synthesis and the proliferative response to PHA in different primary immunodeficiences. J. Immunol., 128, 679–683.
METCALF, D. (1979). Production of colony-stimulating factors by lymphoid tissues. In Biology of the Lymphokines. Cohen, S., Pick, E. and Oppenheim, J.J. (eds) p. 515, New York: Academic Press.
MIZEL, S.B., DAYER, J.M., KRANE, S.M. and MERGENHAGEN, S.E. (1980). Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc. natn. Acad. Sci. U.S.A., 78, 2474.
MOORE, R., HOFFELD, J., FARRAR, J., MERGENHAGEN, S., OPPENHEIM, J.J. and SHADDUCK, R. (1981). Role of colony stimulating factors as primary regulators of macrophage functions. In Lymphokines vol. 3. Pick. E. and Landy, M. (eds), pp. 119–148. New York: Academic Press.
MURAGUCHI, A., BUTLER, J.L., KEHRL, J.H. and FAUCI, A.S. (1983). Differential sensitivity of human B cell subsets to activation signals delivered by anti-antibody and proliferative signals delivered by a monoclonal B cell growth factor. J. exp. Med., 157, 530–546.
NAKAMURA, T., MIYASAKA, N., TALAL, N. and RUSSELL, I.J. (1982). Interleukin 2 related regulatory defects in autoimmune diseases. Arthritis Rheum., 25, 83.
NAKAYAMA, E., ASANO, S., TAKUWA, N., YOKOTA, J. and MIWA, S. (1983). Decreased TCGF activity in the culture medium of PHA stimulated peripheral mononuclear cells from patients with metastatic cancer. Clin. exp. Immunol., 51, 511–516.
NEUMANN, C. and SORG, C. (1980). Sequential expression of functions during macrophage differentiation in murine marrow liquid cultures. Eur. J. Immunol., 10, 834–840.
OKADA, M., SAKAGUCHI, N., YOSHIMURA, N., HARA, H., SHIMIZU, K., YOSHIDA, N., YOSHIKAZI, K., KISHIMOTO, S., YAMAMURA, Y. and KISHIMOTO, T. (1983). B cell growth factors and B cell differentiation factor from human T hybridomas. Two distinct kinds of B cell growth factor and their synergism in B cell proliferation. J. exp. Med., 157, 583–590.
PAGANELLI, R., AIUTI, F., BEVERLEY, P.C.L. and LEVINSKY, R.J. (1983). Impaired production on interleukins in patients with cell-mediated immunodeficiencies. Clin. exp. Immunol., 51, 338–344.
POSTLEWHAITE, A.E., LACHMAN, L.B., MAINARDI, C.L. and KANG, A.H. (1983). Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J. exp. Med., 157, 801–806.
RAULET, D.H. and BEVAN, M.J. (1982). A differentiation factor required for the expression of cytotoxic T-cell function. Nature, 296, 754–757.
ROBB, R.J., MUNCK, A. and SMITH, K.A. (1981). T cell growth factor receptors: quantitation, specificity and biological relevance. J. exp. Med., 154, 1455–1474.
SCHIMPL, A. and WECKER, E. (1973). Stimulation of IgG antibody response in vitro by T cell replacing factor. J. exp. Med., 137, 547–552.
SCHIMPL, A., HUBNER, L., WONG, C. and WECKER, E. (1980). Distinction between T helper cell replacing factor (TRF) and T cell growth factor (TCGF). Behring Inst. Mitt., 67, 211–218.
SCHIMIDT, J.A., MIZEL, S.B., COHEN, D. and GREEN, I. (1982). Interleukin 1 a potential regulator of fibroblast proliferation. J. Immunol., 128, 2177–2182.
SCHRADER, J.W. and CLARK-LEWIS, I. (1982). A T-cell derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony stimulating factor. J. Immunol., 129, 30–35.
SIPE, J.D., VOGEL, S.N., RYAN, J.L., McADAM, K.P. and ROSENSTREICH, D.L. (1979). Detection of a mediator derived from the endotoxin-stimulated macrophages that induces the acute phase serum amyloid A response in mice. J. exp. Med., 150, 597–606.
SMITH, K.A., LACHMAN, L.B., OPPENHEIM, J.J. and FAVATA, M.F. (1980). The functional relationship of the interleukins. J. exp. Med., 151, 1551–1556.
SORG, C. and NEUMANN, C. (1981). A development concept for the heterogeneity of macrophages in response to lymphokines and other signals. In Lymphokines, vol. 3. Pick, E. and Landy, M. (eds) pp. 85–118, New York: Academic Press.
STADLER, B.M., DOUGHERTY, S., FARRAR, J.J. and OPPENHEIM, J.J. (1981). Relationship of cell cycle to recovery of IL2 activity from human mononuclear cells, human and mouse T cell lines. J. Immunol., 127, 1936–1940.
TADOKORO, K., STADLER, B. and de WECK, A.L. (1983). Factor-dependent in vivo growth of human normal bone marrow-derived basophil-like cells. J. exp. Med., 158, 857–871.
TANIGUCHI, T., MATSUI, H., FUJITA, T., TAKOKA, C., KASHIMA, R., YOSHIMOTO, R. and HAMURO, J. (1983). Structure and expression of a cloned cDNA for human interleukin 2. Nature, 302, 305–310.
THOMAN, M.L. and WEIGLE, W.O. (1981). Lymphokines and aging: Interleukin 2 production and activity in aged animals. J. Immunol., 127, 2102–2106.
THOMAN, M.L. and WEIGLE, W.O. (1982). Cell-mediated immunity in aged mice: an underlying lesion in IL 2 synthesis. J. Immunol., 128, 2358–2361.
TING, C.C., YANG, S.S. and HARGROVE, M.E. (1984). Induction of suppressor cells by interleukin 2. J. Immunol., 133, 261–266.
VAN WAUVE, J.P., GOOSSENS, J.G. and BEVERLEY, P.C.L. (1984). Human T lymphocyte activation by monoclonal antibodies: OKT3 but not UCHT1 triggers mitogenesis via an interleukin-2 dependent mechanism. J. Immunol., 133, 129–132.
WAGNER, H., HARDT, C., HEEG, K., RÖLLINGHOF, M. and PFIZENMAIER, K. (1980). T cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/numice. Nature, 284, 278–280.
WEISS, A., WISKOCIL, R.L. and STOBO, J.D. (1984). The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at pre-translational level. J. Immunol., 133, 123–128.
WILKINS, J.A., SIGURDSON, L., JORDON, Y., RUTHERFORD, W.J. and WARRINGTON, R.J. (1983). Immunoregulatory factors from a human macrophage-like cell line. II. A human T-cell lymphokine-induced suppressor factor for lymphocyte proliferation. Cell. Immunol., 77, 329–337.
YOSHIOKA, K., KAKUMU, S., MURAKAMI, H. and FUKUI, K. (1984). Interleukin-2 activity in chronic active liver diseases: response by T cells and in the autologous mixed lymphocyte reaction. Clin. exp. Immunol., 56, 668–676.
YUNG, Y.P., EGER, R., TERTIAN, G. and MOORE, M.A.S. (1981). Long term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF. J. Immunol., 127, 794–804.
Author information
Authors and Affiliations
Editor information
Copyright information
© 1984 Macmillan Publishers Limited
About this chapter
Cite this chapter
de Weck, A.L., Stadler, B., Kristensen, F., Bettens, F., Joncourt, F., Walker, C. (1984). Interleukin 2 and other immunoregulatory T cell lymphokines: biological significance. In: Paton, W., Mitchell, J., Turner, P., Padgham, C., Ashcroft, E. (eds) IUPHAR 9th International Congress of Pharmacology London 1984. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-17615-1_43
Download citation
DOI: https://doi.org/10.1007/978-1-349-17615-1_43
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-0-333-37136-7
Online ISBN: 978-1-349-17615-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)